طب الأورام
كل التخصصات
إسطنبول
كل البلدان
اختر مدينة
طب الأورام
كل التخصصات
إسطنبول
كل البلدان
اختر مدينة

أفضل أطباء الأورام في إسطنبول - توب -96 أطباء

يلبي المحتوى سياسة التحرير Bookimed ويتم مراجعتها طبياً من قبل
فهد مولود - طبيب عام. حاصل على 4 جوائز علمية. خدم في غرب آسيا. رئيس الفريق الطبي الناطق بالعربية سابقا ومسؤول عن معالجة البيانات ودقة المحتوى الطبي حاليا.
Ferhat Ferhatoglu
أخصائي الأورام السريرية
10سنة خبره ١٦ سنة
4.9
21 تقييمات
تركيا, إسطنبول
Valued Med Hub Hospitals

Ferhat Ferhatoglu

أخصائي الأورام السريرية
10سنة خبره ١٦ سنة

Education and Specialization

2017 Istanbul University Istanbul Faculty of Medicine, Department of Internal Medicine, Department of Internal Medicine

19 November 2020 Istanbul University Istanbul Faculty of Medicine, Department of Medical Oncology

2011-25 June 2015 Hospitals/ Istanbul Haydarpasa Numune Education and Research Hospital

2004 Mersin University Faculty of Medicine

 

Experience

13.11.2017-29.03.2021 Istanbul University Istanbul Faculty of Medicine Internal Medicine Departments, Department of Internal Medicine

21.03.2011-25.06.2015 Istanbul Haydarpasa Numune Education and Research Hospital



Ferhatoğlu Ferhat, Çağatay Tülin, Okumuş Nigar Gülfer, Aydıner Adnan, Paksoy Nail, Ak Naziye, Aydın Esra, Saip Pınar Mualla (2023). Laterality Of Adrenal Gland Metastasis İn Lung Cancer: Results Of A Comparative Study. Eurasian Journal Of Medical Investigatin, 7(2), 101-106., Doi: 10.14744/Ejmi.2023.58954

FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942

FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942

FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942

FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942

FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942

FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942

FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942

TAŞTEKİN DİDEM, PAKSOY NAİL, DOĞAN İZZET, FERHATOĞLU FERHAT, KHANMAMMADOV NIJAT, BOZBEY HAMZA UĞUR, KARABULUT SENEM (2023). Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first?line treatment of metastatic gastric cancer: A single?center experience. Journal of Cancer Research and Therapeutics, 19(2), 253-258., Doi: 10.4103/jcrt.jcrt_672_22 (Çeyreklik Dilim=Q4)

KAPAĞAN TANJU, FERHATOĞLU FERHAT (2023). Prognostic Factors for Intensive Care Unit (ICU) Admission among Hospitalized Gastrointestinal and Hepatopancreatobiliary Cancer Patients with Systemic Urinary Tract Infection. Eurasian Journal of Medical Investigation, 7(2), 107-115., Doi: 10.14744/ejmi.2023.81340

KAPAĞAN TANJU, FERHATOĞLU FERHAT (2023). Prognostic Factors for Intensive Care Unit (ICU) Admission among Hospitalized Gastrointestinal and Hepatopancreatobiliary Cancer Patients with Systemic Urinary Tract Infection. Eurasian Journal of Medical Investigation, 7(2), 107-115., Doi: 10.14744/ejmi.2023.81340

FERHATOĞLU FERHAT, AYDINER ADNAN, PAKSOY NAİL (2022). Evaluation of clinical features and risk factors related to late recurrence (>5 years) in patients with breast cancer. Journal of Surgery and Medicine, 6(12), 986-990., Doi: 10.28982/josam.7610

FERHATOĞLU FERHAT, ERTÜRK KAYHAN, TAŞ FARUK (2022). Cutaneous melanoma survival rates of the elderly are not worse than those of the young, yet they have some specific differences. Journal of Cancer Research and Therapeutics, 0, Doi: 10.4103/jcrt.jcrt_815_21

ÖZGÜR EMRE, FERHATOĞLU FERHAT, ŞEN FATMA, GEZER UĞUR (2022). Effect of Cytotoxic Therapy on ALU Expression is Modulated by Hormonal Status in Patients with Breast Cancer. BALKAN MEDICAL JOURNAL, 39(6), 450-451., Doi: 10.4274/balkanmedj.galenos.2022.2022-5-18

Makaleler

TAŞ FARUK, ERTÜRK KAYHAN, FERHATOĞLU FERHAT (2022). Auricular and periauricular melanomas have similar clinicopathologic factors and survival rates. JOURNAL OF COSMETIC DERMATOLOGY, 21(4), 1570-1573., Doi: 10.1111/jocd.14278

TAŞ FARUK, ERTÜRK KAYHAN, FERHATOĞLU FERHAT (2022). Completion Lymph Node Dissection Is Unnecessary After Positive Sentinel Lymph Node in Melanoma — a Case Series Analysis. Indian Journal of Surgery, Doi: 10.1007/s12262-022-03532-y

DOĞAN İZZET, GÜRBÜZ MUSTAFA, PAKSOY NAİL, FERHATOĞLU FERHAT, VATANSEVER SEZAİ, SAİP PINAR, DEMİRKAZIK AHMET, AYDINER ADNAN (2022). Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC. Medicine, 101(34), 30188, Doi: 10.1097/MD.0000000000030188

PAKSOY NAİL, KHANMAMMADOV NIJAT, DOĞAN İZZET, FERHATOĞLU FERHAT, YILDIZ ANIL, AK NAZİYE, AYDINER ADNAN (2022). Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study. Medicine, 101(45), 31726, Doi: 10.1097/MD.0000000000031726

PAKSOY NAİL, FERHATOĞLU FERHAT, DOĞAN İZZET, KHANMAMMADOV NIJAT, İRİBAŞ ÇELİK AYÇA, GÜLBAŞ ZAFER, BAŞARAN MERT (2022). High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing’s sarcoma: A single institution experience. Medicine, 101(49), 32213, Doi: 10.1097/MD.0000000000032213

ÇİL İBRAHİM, KÜÇÜKARDA AHMET, ATCI MUHAMMED MUSTAFA, SECMELER SABAN, PAKSOY NAİL, FERHATOĞLU FERHAT, AK NAZİYE, AYHAN MURAT, TATAROĞLU ÖZYÜKSELER DENİZ, ÖNDER ARİF HAKAN, AVCI OKAN, OYMAN ABDİLKERİM, OKTEN ILKER NİHAT, GÜLTÜRK İLKAY, AKAGÜNDÜZ BARAN, BAŞOĞLU TÜYLÜ TUĞBA, ÇAKIR EMRE, HACIBEKİROĞLU İLHAN, ÖZÇELİK MELİKE, AYDINER ADNAN (2022). Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori Journal, 108(1), 19-25., Doi: 10.1177/03008916211037739

DOĞAN İZZET, KARABULUT SENEM, TAŞTEKİN DİDEM, FERHATOĞLU FERHAT, PAKSOY NAİL, ŞAKAR BURAK (2022). Evaluation of Prognostic Factors and Trastuzumab-based Treatments in HER2/Neu-positive Metastatic Gastric Cancer. Journal of the College of Physicians and Surgeons Pakistan, 32(8), 1014-1019., Doi: 10.29271/jcpsp.2022.08.1014

FERHATOĞLU FERHAT, TUĞCU MURAT, APAYDIN SÜHEYLA (2022). Factors Affecting Postoperative Morbidity and Mortality in Chronic Hemodialysis Patients. Eurasian Journal of Medical Advances, 2(3), 30-38., Doi: 10.14744/ejma.2022.43153

KAPAĞAN TANJU, FERHATOĞLU FERHAT, EMEKLİ SELİNAY, KILIÇ ÇAĞLA ECEM (2022). Risk Factors for Cutaneous Melanomas and Level of Awareness in Society. Journal of the Turkish Academy of Dermatology, 16(4), 94-100., Doi: 10.4274/jtad.galenos.2022.30092

FERHATOĞLU FERHAT, ALTAN FERHATOĞLU ZEYNEP (2022). Frequency, Demographic and Clinicopathological Characteristics of Skin Cancer Patients Treated and Followed Up in the Medical Oncology Outpatient Clinic. Journal of the Turkish Academy of Dermatology, 16(4), 77-81., Doi: 10.4274/jtad.galenos.2022.04706

KARABULUT SENEM, DOĞAN İZZET, USUL AFŞAR ÇİĞDEM, KARABULUT MEHMET, KARAMAN ŞULE, FERHATOĞLU FERHAT, TAŞTEKİN DİDEM (2021). Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? Results of a prospective multicenter study. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 27(6), 1357- 1363., Doi: 10.1177/1078155220959427

AK NAZİYE, ÖZKAN BERKER, YENİGÜN BÜLENT MUSTAFA, YILMAZBAYHAN EMİNE DİLEK, TOKER SEYFİ ALPER, FERHATOĞLU FERHAT, YAŞAR HATİME ARZU, DİZBAY SAK SERPİL, TANJU SERHAT, DİLEGE MUSTAFA ŞÜKRÜ, ERUS SUAT, BULUTAY PINAR, FIRAT PINAR, MANDEL NİL MOLİNAS, KILIÇKAP SAADETTİN, ONDER SEVGEN, DİKMEN ERKAN, ALAN ÖZKAN, YUMUK PERRAN FULDEN, BOZKURTLAR EMİNE, LAÇİN TUNÇ, YILDIZELİ BEDRETTİN, ÖZTÜRK AKIN, KOCATÜRK CELALETTİN İBRAHİM, KARAPINAR KEMAL, ÜRER HALİDE NUR, OYAN ULUÇ BAŞAK, AYDINER ADNAN, DEMİRKAZIK AHMET, ERALP YEŞİM (2021). The role of adjuvant chemotherapy in resected stage I non – small cell lung cancer: A Turkish Oncology Group Study.. Journal of BUON, 26(3), 819-829.

AK NAZİYE, TOKER SEYFİ ALPER, KARA MURAT, ÖZKAN BERKER, ÜLKER MELİKE GÜLER, KABA ERKAN, YEGEN GÜLÇİN, KARAMAN ŞULE, DAĞOĞLU SAKİN RABİA NERGİZ, KAYTAN SAĞLAM ESRA, ORAL ETHEM NEZİH, KİZİR AHMET, BAYRAKTAR SOLEY, DİŞÇİ RİAN, FERHATOĞLU FERHAT, AYDIN ESRA, VATANSEVER SEZAİ, ERALP YEŞİM, AYDINER ADNAN (2021). Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center. TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 29(4), 487- 495., Doi: 10.5606/tgkdc.dergisi.2021.20529

AK NAZİYE, PAKSOY NAİL, FERHATOĞLU FERHAT, AYDIN ESRA, DOĞAN İZZET, BEKTAŞ ERDEM, KARACA MERT, OĞUZ SOYDİNÇ HİLAL, MİNARECİ YAĞMUR, SÖZEN HAMDULLAH, TOPUZ SAMET, SAİP PINAR MUALLA, VATANSEVER SEZAİ (2021). Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma. TURKISH JOURNAL of ONCOLOGY, 36(4), 438-445., Doi: 10.5505/tjo.2021.2882

اقرأ المزيد

Education and Specialization

2017 Istanbul University Istanbul Faculty of Medicine, Department of Internal Medicine, Department of Internal Medicine

19 November 2020 Istanbul University Istanbul Faculty of Medicine, Department of Medical Oncology

2011-25 June 2015 Hospitals/ Istanbul Haydarpasa Numune Education and Research Hospital

2004 Mersin University Faculty of Medicine

 

Experience

13.11.2017-29.03.2021 Istanbul University Istanbul Faculty of Medicine Internal Medicine Departments, Department of Internal Medicine

21.03.2011-25.06.2015 Istanbul Haydarpasa Numune Education and Research Hospital



Ferhatoğlu Ferhat, Çağatay Tülin, Okumuş Nigar Gülfer, Aydıner Adnan, Paksoy Nail, Ak Naziye, Aydın Esra, Saip Pınar Mualla (2023). Laterality Of Adrenal Gland Metastasis İn Lung Cancer: Results Of A Comparative Study. Eurasian Journal Of Medical Investigatin, 7(2), 101-106., Doi: 10.14744/Ejmi.2023.58954

FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942

FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942

FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942

FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942

FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942

FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942

FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942

TAŞTEKİN DİDEM, PAKSOY NAİL, DOĞAN İZZET, FERHATOĞLU FERHAT, KHANMAMMADOV NIJAT, BOZBEY HAMZA UĞUR, KARABULUT SENEM (2023). Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first?line treatment of metastatic gastric cancer: A single?center experience. Journal of Cancer Research and Therapeutics, 19(2), 253-258., Doi: 10.4103/jcrt.jcrt_672_22 (Çeyreklik Dilim=Q4)

KAPAĞAN TANJU, FERHATOĞLU FERHAT (2023). Prognostic Factors for Intensive Care Unit (ICU) Admission among Hospitalized Gastrointestinal and Hepatopancreatobiliary Cancer Patients with Systemic Urinary Tract Infection. Eurasian Journal of Medical Investigation, 7(2), 107-115., Doi: 10.14744/ejmi.2023.81340

KAPAĞAN TANJU, FERHATOĞLU FERHAT (2023). Prognostic Factors for Intensive Care Unit (ICU) Admission among Hospitalized Gastrointestinal and Hepatopancreatobiliary Cancer Patients with Systemic Urinary Tract Infection. Eurasian Journal of Medical Investigation, 7(2), 107-115., Doi: 10.14744/ejmi.2023.81340

FERHATOĞLU FERHAT, AYDINER ADNAN, PAKSOY NAİL (2022). Evaluation of clinical features and risk factors related to late recurrence (>5 years) in patients with breast cancer. Journal of Surgery and Medicine, 6(12), 986-990., Doi: 10.28982/josam.7610

FERHATOĞLU FERHAT, ERTÜRK KAYHAN, TAŞ FARUK (2022). Cutaneous melanoma survival rates of the elderly are not worse than those of the young, yet they have some specific differences. Journal of Cancer Research and Therapeutics, 0, Doi: 10.4103/jcrt.jcrt_815_21

ÖZGÜR EMRE, FERHATOĞLU FERHAT, ŞEN FATMA, GEZER UĞUR (2022). Effect of Cytotoxic Therapy on ALU Expression is Modulated by Hormonal Status in Patients with Breast Cancer. BALKAN MEDICAL JOURNAL, 39(6), 450-451., Doi: 10.4274/balkanmedj.galenos.2022.2022-5-18

Makaleler

TAŞ FARUK, ERTÜRK KAYHAN, FERHATOĞLU FERHAT (2022). Auricular and periauricular melanomas have similar clinicopathologic factors and survival rates. JOURNAL OF COSMETIC DERMATOLOGY, 21(4), 1570-1573., Doi: 10.1111/jocd.14278

TAŞ FARUK, ERTÜRK KAYHAN, FERHATOĞLU FERHAT (2022). Completion Lymph Node Dissection Is Unnecessary After Positive Sentinel Lymph Node in Melanoma — a Case Series Analysis. Indian Journal of Surgery, Doi: 10.1007/s12262-022-03532-y

DOĞAN İZZET, GÜRBÜZ MUSTAFA, PAKSOY NAİL, FERHATOĞLU FERHAT, VATANSEVER SEZAİ, SAİP PINAR, DEMİRKAZIK AHMET, AYDINER ADNAN (2022). Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC. Medicine, 101(34), 30188, Doi: 10.1097/MD.0000000000030188

PAKSOY NAİL, KHANMAMMADOV NIJAT, DOĞAN İZZET, FERHATOĞLU FERHAT, YILDIZ ANIL, AK NAZİYE, AYDINER ADNAN (2022). Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study. Medicine, 101(45), 31726, Doi: 10.1097/MD.0000000000031726

PAKSOY NAİL, FERHATOĞLU FERHAT, DOĞAN İZZET, KHANMAMMADOV NIJAT, İRİBAŞ ÇELİK AYÇA, GÜLBAŞ ZAFER, BAŞARAN MERT (2022). High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing’s sarcoma: A single institution experience. Medicine, 101(49), 32213, Doi: 10.1097/MD.0000000000032213

ÇİL İBRAHİM, KÜÇÜKARDA AHMET, ATCI MUHAMMED MUSTAFA, SECMELER SABAN, PAKSOY NAİL, FERHATOĞLU FERHAT, AK NAZİYE, AYHAN MURAT, TATAROĞLU ÖZYÜKSELER DENİZ, ÖNDER ARİF HAKAN, AVCI OKAN, OYMAN ABDİLKERİM, OKTEN ILKER NİHAT, GÜLTÜRK İLKAY, AKAGÜNDÜZ BARAN, BAŞOĞLU TÜYLÜ TUĞBA, ÇAKIR EMRE, HACIBEKİROĞLU İLHAN, ÖZÇELİK MELİKE, AYDINER ADNAN (2022). Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori Journal, 108(1), 19-25., Doi: 10.1177/03008916211037739

DOĞAN İZZET, KARABULUT SENEM, TAŞTEKİN DİDEM, FERHATOĞLU FERHAT, PAKSOY NAİL, ŞAKAR BURAK (2022). Evaluation of Prognostic Factors and Trastuzumab-based Treatments in HER2/Neu-positive Metastatic Gastric Cancer. Journal of the College of Physicians and Surgeons Pakistan, 32(8), 1014-1019., Doi: 10.29271/jcpsp.2022.08.1014

FERHATOĞLU FERHAT, TUĞCU MURAT, APAYDIN SÜHEYLA (2022). Factors Affecting Postoperative Morbidity and Mortality in Chronic Hemodialysis Patients. Eurasian Journal of Medical Advances, 2(3), 30-38., Doi: 10.14744/ejma.2022.43153

KAPAĞAN TANJU, FERHATOĞLU FERHAT, EMEKLİ SELİNAY, KILIÇ ÇAĞLA ECEM (2022). Risk Factors for Cutaneous Melanomas and Level of Awareness in Society. Journal of the Turkish Academy of Dermatology, 16(4), 94-100., Doi: 10.4274/jtad.galenos.2022.30092

FERHATOĞLU FERHAT, ALTAN FERHATOĞLU ZEYNEP (2022). Frequency, Demographic and Clinicopathological Characteristics of Skin Cancer Patients Treated and Followed Up in the Medical Oncology Outpatient Clinic. Journal of the Turkish Academy of Dermatology, 16(4), 77-81., Doi: 10.4274/jtad.galenos.2022.04706

KARABULUT SENEM, DOĞAN İZZET, USUL AFŞAR ÇİĞDEM, KARABULUT MEHMET, KARAMAN ŞULE, FERHATOĞLU FERHAT, TAŞTEKİN DİDEM (2021). Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? Results of a prospective multicenter study. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 27(6), 1357- 1363., Doi: 10.1177/1078155220959427

AK NAZİYE, ÖZKAN BERKER, YENİGÜN BÜLENT MUSTAFA, YILMAZBAYHAN EMİNE DİLEK, TOKER SEYFİ ALPER, FERHATOĞLU FERHAT, YAŞAR HATİME ARZU, DİZBAY SAK SERPİL, TANJU SERHAT, DİLEGE MUSTAFA ŞÜKRÜ, ERUS SUAT, BULUTAY PINAR, FIRAT PINAR, MANDEL NİL MOLİNAS, KILIÇKAP SAADETTİN, ONDER SEVGEN, DİKMEN ERKAN, ALAN ÖZKAN, YUMUK PERRAN FULDEN, BOZKURTLAR EMİNE, LAÇİN TUNÇ, YILDIZELİ BEDRETTİN, ÖZTÜRK AKIN, KOCATÜRK CELALETTİN İBRAHİM, KARAPINAR KEMAL, ÜRER HALİDE NUR, OYAN ULUÇ BAŞAK, AYDINER ADNAN, DEMİRKAZIK AHMET, ERALP YEŞİM (2021). The role of adjuvant chemotherapy in resected stage I non – small cell lung cancer: A Turkish Oncology Group Study.. Journal of BUON, 26(3), 819-829.

AK NAZİYE, TOKER SEYFİ ALPER, KARA MURAT, ÖZKAN BERKER, ÜLKER MELİKE GÜLER, KABA ERKAN, YEGEN GÜLÇİN, KARAMAN ŞULE, DAĞOĞLU SAKİN RABİA NERGİZ, KAYTAN SAĞLAM ESRA, ORAL ETHEM NEZİH, KİZİR AHMET, BAYRAKTAR SOLEY, DİŞÇİ RİAN, FERHATOĞLU FERHAT, AYDIN ESRA, VATANSEVER SEZAİ, ERALP YEŞİM, AYDINER ADNAN (2021). Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center. TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 29(4), 487- 495., Doi: 10.5606/tgkdc.dergisi.2021.20529

AK NAZİYE, PAKSOY NAİL, FERHATOĞLU FERHAT, AYDIN ESRA, DOĞAN İZZET, BEKTAŞ ERDEM, KARACA MERT, OĞUZ SOYDİNÇ HİLAL, MİNARECİ YAĞMUR, SÖZEN HAMDULLAH, TOPUZ SAMET, SAİP PINAR MUALLA, VATANSEVER SEZAİ (2021). Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma. TURKISH JOURNAL of ONCOLOGY, 36(4), 438-445., Doi: 10.5505/tjo.2021.2882

اقرأ المزيد
Murat Atay
جراح عام
31سنة خبره ١٦ سنة
5.0
19 تقييمات
تركيا, إسطنبول
Group Florence Nightingale Hospitals

Murat Atay

جراح عام
31سنة خبره ١٦ سنة

Education:

Teaching course on “Lymphatic mapping and sentinel node”

June 1998, MDA Cancer Center, Houston, Texas, USA

 

General Surgery

Feb. 1993 – Dec. 1996, Şişli Etfal Hospital, Istanbul, Turkey

 

General Surgery

May 1990 – Jan. 1993, Lille University Hospital, Lille, France 

 

M.D.

1983 – 1990, Cerrahpasa School of Medicine, Istanbul, Turkey

 

Experience

 

Attending General Surgeon, Jan. 1998 – present 

F.N. Metropolitan Hospital, Istanbul, Turkey

American Cancer Center, Breast Surgery

 

Attending General Surgeon, 1996 – present 

Medmar Diagnostic Center, Istanbul, Turkey

Diagnosis and monitoring with sophisticated techniques 

 

General Surgeon, 1996 – 1998

Guzelbahce Medical Center and Yeditepe Hospital, Istanbul, Turkey

Specializing in breast and thyroid surgery

 

اقرأ المزيد

Education:

Teaching course on “Lymphatic mapping and sentinel node”

June 1998, MDA Cancer Center, Houston, Texas, USA

 

General Surgery

Feb. 1993 – Dec. 1996, Şişli Etfal Hospital, Istanbul, Turkey

 

General Surgery

May 1990 – Jan. 1993, Lille University Hospital, Lille, France 

 

M.D.

1983 – 1990, Cerrahpasa School of Medicine, Istanbul, Turkey

 

Experience

 

Attending General Surgeon, Jan. 1998 – present 

F.N. Metropolitan Hospital, Istanbul, Turkey

American Cancer Center, Breast Surgery

 

Attending General Surgeon, 1996 – present 

Medmar Diagnostic Center, Istanbul, Turkey

Diagnosis and monitoring with sophisticated techniques 

 

General Surgeon, 1996 – 1998

Guzelbahce Medical Center and Yeditepe Hospital, Istanbul, Turkey

Specializing in breast and thyroid surgery

 

اقرأ المزيد
Omer Uslukaya
جراح عام
22سنة خبره ١٦ سنة
4.5
39 تقييمات
تركيا, إسطنبول
Memorial Ataşehir Hospital

Omer Uslukaya

جراح عام
22سنة خبره ١٦ سنة

EXPERIENCE*

 

2019 - Present, Istanbul/Istanbul/Turkey

MEMORIAL ATAŞEHİR HOSPITAL

General Surgeon

2012 - 2019, Diyarbakır/Diyarbakır/Turkey

DİCLE UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2011 - 2012, Van/Van/Turkey

VAN REGIONAL TRAINING AND RESEARCH HOSPITAL

General Surgeon

2009 - 2011, Van/Van/Turkey

HAKKARİ STATE HOSPITAL

General Surgeon

2004 - 2009, Van/Van/Turkey

YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2002 - 2004, Van/Van/Turkey

HACIBEKİR HEALTH CENTER

General Practitioner

 

*EDUCATION*

 

2018 - 2019, Diyarbakır/Turkey

Associate Professor

2015, Ohio/USA

OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER

Neck Dissection Training

2012 - 2018, Diyarbakır/Turkey

Assistant Professor

1996 - 2002, Adana/Turkey

ÇUKUROVA UNIVERSITY

FACULTY OF MEDICINE - Medical Doctor Education

اقرأ المزيد

EXPERIENCE*

 

2019 - Present, Istanbul/Istanbul/Turkey

MEMORIAL ATAŞEHİR HOSPITAL

General Surgeon

2012 - 2019, Diyarbakır/Diyarbakır/Turkey

DİCLE UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2011 - 2012, Van/Van/Turkey

VAN REGIONAL TRAINING AND RESEARCH HOSPITAL

General Surgeon

2009 - 2011, Van/Van/Turkey

HAKKARİ STATE HOSPITAL

General Surgeon

2004 - 2009, Van/Van/Turkey

YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2002 - 2004, Van/Van/Turkey

HACIBEKİR HEALTH CENTER

General Practitioner

 

*EDUCATION*

 

2018 - 2019, Diyarbakır/Turkey

Associate Professor

2015, Ohio/USA

OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER

Neck Dissection Training

2012 - 2018, Diyarbakır/Turkey

Assistant Professor

1996 - 2002, Adana/Turkey

ÇUKUROVA UNIVERSITY

FACULTY OF MEDICINE - Medical Doctor Education

اقرأ المزيد
4.5
39 تقييمات
تكلفة استشارة الطبيب السعر عند الطلب
جراحة البروستاتا (انظر. استئصال البروستاتا) $9000 - $11000
الترددات اللاسلكية
إزالة ورم في المخ $10000 - $15000
المزيد من الطرق العلاجية
Kezban Nur Pilanci
أخصائي الأورام السريرية
21سنة خبره ١٦ سنة
4.6
97 تقييمات
تركيا, إسطنبول
Memorial Bahçelievler Hospital

Kezban Nur Pilanci

أخصائي الأورام السريرية
21سنة خبره ١٦ سنة

2018 - Halen, İstanbul/İstanbul/Türkiye

MEMORIAL BAHÇELİEVLER HASTANESİ

Medikal Onkoloji Uzmanı

2018 - 2018, İstanbul/İstanbul/Türkiye

İSTANBUL AYDIN ÜNİVERSİTESİ MEDİCAL PARK FLORYA HASTANESİ

Medikal Onkoloji Uzmanı

2015 - 2018, İstanbul/İstanbul/Türkiye

HASEKİ EĞİTİM VE ARAŞTIRMA HASTANESI

Medikal Onkoloji Uzmanı

2011 - 2014, İstanbul/İstanbul/Türkiye

ISTANBUL BİLİM ÜNİVERSİTESİ İÇ HASTALIKLARI ABD

Medikal Onkoloji Asistanı

2011 - 2011, İstanbul/İstanbul/Türkiye

KANUNİ SULTAN EĞİTİM VE ARAŞTIRMA HASTANESİ

İç Hastalıkları Uzmanı

2006 - 2011, İstanbul/İstanbul/Türkiye

İSTANBUL EĞİTİM VE ARAŞTIRMA HASTANESİ

İç Hastalıkları Asistanı

2004 - 2005, İstanbul/İstanbul/Türkiye

İSTANBUL ÜNİVERSİTESİ CERRAHPAŞA TIP FAKÜLTESİ BİYOKİMYA ABD

Araştırma Görevlisi

2003 - 2004, Karabük/Karabük/Türkiye

KARABÜK İLİ SAFRANBOLU 3 NO’LU SAĞLIK OCAĞI

Pratisyen Hekim

اقرأ المزيد

2018 - Halen, İstanbul/İstanbul/Türkiye

MEMORIAL BAHÇELİEVLER HASTANESİ

Medikal Onkoloji Uzmanı

2018 - 2018, İstanbul/İstanbul/Türkiye

İSTANBUL AYDIN ÜNİVERSİTESİ MEDİCAL PARK FLORYA HASTANESİ

Medikal Onkoloji Uzmanı

2015 - 2018, İstanbul/İstanbul/Türkiye

HASEKİ EĞİTİM VE ARAŞTIRMA HASTANESI

Medikal Onkoloji Uzmanı

2011 - 2014, İstanbul/İstanbul/Türkiye

ISTANBUL BİLİM ÜNİVERSİTESİ İÇ HASTALIKLARI ABD

Medikal Onkoloji Asistanı

2011 - 2011, İstanbul/İstanbul/Türkiye

KANUNİ SULTAN EĞİTİM VE ARAŞTIRMA HASTANESİ

İç Hastalıkları Uzmanı

2006 - 2011, İstanbul/İstanbul/Türkiye

İSTANBUL EĞİTİM VE ARAŞTIRMA HASTANESİ

İç Hastalıkları Asistanı

2004 - 2005, İstanbul/İstanbul/Türkiye

İSTANBUL ÜNİVERSİTESİ CERRAHPAŞA TIP FAKÜLTESİ BİYOKİMYA ABD

Araştırma Görevlisi

2003 - 2004, Karabük/Karabük/Türkiye

KARABÜK İLİ SAFRANBOLU 3 NO’LU SAĞLIK OCAĞI

Pratisyen Hekim

اقرأ المزيد
Nuri Kaydihan
أخصائي الأورام الإشعاعية
8سنة خبره ١٦ سنة
4.6
97 تقييمات
تركيا, إسطنبول
Memorial Bahçelievler Hospital

Nuri Kaydihan

أخصائي الأورام الإشعاعية
8سنة خبره ١٦ سنة

2018 - Halen, İstanbul/İstanbul/Türkiye

MEMORIAL BAHÇELİEVLER HASTANESİ

Radyasyon Onkolojisi Uzmanı

2016 - 2018, İstanbul/İstanbul/Türkiye

İSTANBUL ÜNİVERSİTESİ CERRAHPAŞA TIP FAKÜLTESİ

Radyasyon Onkolojisi Uzmanı

اقرأ المزيد

2018 - Halen, İstanbul/İstanbul/Türkiye

MEMORIAL BAHÇELİEVLER HASTANESİ

Radyasyon Onkolojisi Uzmanı

2016 - 2018, İstanbul/İstanbul/Türkiye

İSTANBUL ÜNİVERSİTESİ CERRAHPAŞA TIP FAKÜLTESİ

Radyasyon Onkolojisi Uzmanı

اقرأ المزيد
Binnur Simsek
أخصائي أمراض الجهاز الهضمي
37سنة خبره ١٦ سنة
4.5
215 تقييمات
تركيا, إسطنبول
Liv Hospital Ulus

Binnur Simsek

أخصائي أمراض الجهاز الهضمي
37سنة خبره ١٦ سنة

Medical Interests and Activities 

Hepatic Cirrhosis and Portal Hypertension 

Hepatic Cancer 

Viral Hepatitides (Chronic Hepatitis B, C and Delta Infections) 

Alcoholic Chronic Liver Disease 

Non-Alcoholic Fatty Liver Disease 

Stomach and Duodenal Ulcer 

Gastrointestinal Hemorrhage (Ulcer and Varicose Vein Bleeding) 

Functional Digestive System Disorders (Irritable Bowel Syndrome, Functional Intestinal Obstruction and Diarrhea...) 

Inflammatory Bowel Diseases (Ulcerative Colitis, Crohn’s Disease) 

Malabsorption Syndromes (Celiac Disease and Alike) 

Gastrointestinal Tract Malignancies

Education and Experience 

Liv Hospital, Ulus, Gastroenterohepatology Department (2013 ...) 

Associate Professor of Medicine, Obligatory Service at Gastroenterology, Şanlıurfa Training and Research Hospital (2010-2012) 

Subspecialty in Gastroenterohepatology, Department of Gastroenterohepatology, İstanbul Faculty of Medicine, İstanbul University (2004-2010) 

Research Fellow, Physician, Department of Internal Diseases, 

İstanbul Faculty of Medicine, İstanbul University (1992 - 1998)

Memberships 

Turkish Association For The Study of The Liver 

Turkish Society of Gastroenterology 

Inflammatory Bowel Disease Society 

Internal Diseases Specialty Association

اقرأ المزيد

Medical Interests and Activities 

Hepatic Cirrhosis and Portal Hypertension 

Hepatic Cancer 

Viral Hepatitides (Chronic Hepatitis B, C and Delta Infections) 

Alcoholic Chronic Liver Disease 

Non-Alcoholic Fatty Liver Disease 

Stomach and Duodenal Ulcer 

Gastrointestinal Hemorrhage (Ulcer and Varicose Vein Bleeding) 

Functional Digestive System Disorders (Irritable Bowel Syndrome, Functional Intestinal Obstruction and Diarrhea...) 

Inflammatory Bowel Diseases (Ulcerative Colitis, Crohn’s Disease) 

Malabsorption Syndromes (Celiac Disease and Alike) 

Gastrointestinal Tract Malignancies

Education and Experience 

Liv Hospital, Ulus, Gastroenterohepatology Department (2013 ...) 

Associate Professor of Medicine, Obligatory Service at Gastroenterology, Şanlıurfa Training and Research Hospital (2010-2012) 

Subspecialty in Gastroenterohepatology, Department of Gastroenterohepatology, İstanbul Faculty of Medicine, İstanbul University (2004-2010) 

Research Fellow, Physician, Department of Internal Diseases, 

İstanbul Faculty of Medicine, İstanbul University (1992 - 1998)

Memberships 

Turkish Association For The Study of The Liver 

Turkish Society of Gastroenterology 

Inflammatory Bowel Disease Society 

Internal Diseases Specialty Association

اقرأ المزيد
Ademucar
أخصائي أشعة
24سنة خبره ١٦ سنة
4.5
215 تقييمات
تركيا, إسطنبول
Liv Hospital Ulus

Ademucar

أخصائي أشعة
24سنة خبره ١٦ سنة

Medical Interests and Activities 

Interventional Radiology 

Oncological Radiology and Interventions 

Vascular Radiology 

Education and Experience 

Department of Radiology, Liv Hospital, Ulus (2012 -…) 

Interventional Radiology, İstanbul Faculty of Medicine (2006 - 2012) 

Faculty Hospital Hradec Kralove, Faculty of Medicine, Charles University (Observer, 2010) 

Interventional Radiology, Boston Children’s Hospital Vascular Anomaly Center, Harvard University (2008) 

Department of Radiodiagnostic, İstanbul Faculty of Medicine (2001 - 2005) 

Cerrahpaşa Faculty of Medicine

Memberships 

Turkish Society of Radiology 

Turkish Society of Interventional Radiology 

Cardiovascular and Interventional Radiologic Society of Europe 

European Society of Radiology

اقرأ المزيد

Medical Interests and Activities 

Interventional Radiology 

Oncological Radiology and Interventions 

Vascular Radiology 

Education and Experience 

Department of Radiology, Liv Hospital, Ulus (2012 -…) 

Interventional Radiology, İstanbul Faculty of Medicine (2006 - 2012) 

Faculty Hospital Hradec Kralove, Faculty of Medicine, Charles University (Observer, 2010) 

Interventional Radiology, Boston Children’s Hospital Vascular Anomaly Center, Harvard University (2008) 

Department of Radiodiagnostic, İstanbul Faculty of Medicine (2001 - 2005) 

Cerrahpaşa Faculty of Medicine

Memberships 

Turkish Society of Radiology 

Turkish Society of Interventional Radiology 

Cardiovascular and Interventional Radiologic Society of Europe 

European Society of Radiology

اقرأ المزيد
Gulnihal Ozdemir
أخصائي أمراض الدم / أخصائي الأورام
27سنة خبره ١٦ سنة
4.5
215 تقييمات
تركيا, إسطنبول
Liv Hospital Ulus

Gulnihal Ozdemir

أخصائي أمراض الدم / أخصائي الأورام
27سنة خبره ١٦ سنة

Medical Fields of Interest: 

Hemostasis-Thrombosis 

Anemia 

Education: 

Cerrahpasa Faculty Of Medicine Pediatric Hematology Department 

Marmara University Faculty of Medicine, Child Health and Diseases Department  

Besiktas Ataturk Anatolian High School 

Experience: 

Liv Hospital Ulus 

Kanuni Sultan Suleyman Training And Research Hospital 

Cerrahpasa Medical Faculty Hospital 

Austria St George Hospital 

Marmara University Faculty of Medicine Hospital

Memberships: 

Turkish Society of Pediatric Hematology 

Turkish Society of Hematology 

Turkish Pediatric Association 

Istanbul Febrile Neutropenia Group 

European Association of Hematology (EHA) 

American Association of Hematology (ASH) 

International Hemostasis Thrombosis Association (ISTH)

اقرأ المزيد

Medical Fields of Interest: 

Hemostasis-Thrombosis 

Anemia 

Education: 

Cerrahpasa Faculty Of Medicine Pediatric Hematology Department 

Marmara University Faculty of Medicine, Child Health and Diseases Department  

Besiktas Ataturk Anatolian High School 

Experience: 

Liv Hospital Ulus 

Kanuni Sultan Suleyman Training And Research Hospital 

Cerrahpasa Medical Faculty Hospital 

Austria St George Hospital 

Marmara University Faculty of Medicine Hospital

Memberships: 

Turkish Society of Pediatric Hematology 

Turkish Society of Hematology 

Turkish Pediatric Association 

Istanbul Febrile Neutropenia Group 

European Association of Hematology (EHA) 

American Association of Hematology (ASH) 

International Hemostasis Thrombosis Association (ISTH)

اقرأ المزيد
Tahsin Ozatli
أخصائي الأورام السريرية
2014سنة خبره ١٦ سنة
4.3
16 تقييمات
تركيا, إسطنبول
Istinye University Liv Hospital Bahcesehir

Tahsin Ozatli

أخصائي الأورام السريرية
2014سنة خبره ١٦ سنة
دكتور اوراماقرأ المزيد
دكتور اورام
4.3
16 تقييمات
تكلفة استشارة الطبيب السعر عند الطلب
العلاج الكيميائي $2000 - $9000
زرع نخاع العظم $40000 - $110000
الترددات اللاسلكية $6000
المزيد من الطرق العلاجية
Celalettin Camci
أخصائي جراحة الأورام
25سنة خبره ١٦ سنة

Celalettin Camci

أخصائي جراحة الأورام
25سنة خبره ١٦ سنة
تركيا, إسطنبول
HEC Turkey
Dr Ertan Ozen
دكتور امراض نساء
34سنة خبره ١٦ سنة

Dr Ertan Ozen

دكتور امراض نساء
34سنة خبره ١٦ سنة
تركيا, إسطنبول
Academic Hospital
تكلفة استشارة الطبيب السعر عند الطلب
إزالة ورم في المخ $20000 - $40000
المزيد من الطرق العلاجية
Prof Dr Turgay Celikel
أخصائي الأورام السريرية
45سنة خبره ١٦ سنة

Prof Dr Turgay Celikel

أخصائي الأورام السريرية
45سنة خبره ١٦ سنة
تركيا, إسطنبول
Academic Hospital
تكلفة استشارة الطبيب السعر عند الطلب
إزالة ورم في المخ $20000 - $40000
المزيد من الطرق العلاجية